These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24500460)

  • 21. Disparities in use of antipsychotic medications among nursing home residents in Arkansas.
    Hudson TJ; Cody M; Armitage TL; Curtis MA; Sullivan G
    Psychiatr Serv; 2005 Jun; 56(6):749-51. PubMed ID: 15939955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of antipsychotic medications for the dementia patient.
    Devanand DP; Schultz SK
    Am J Psychiatry; 2011 Aug; 168(8):767-9. PubMed ID: 21813491
    [No Abstract]   [Full Text] [Related]  

  • 23. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Yohanna D; Cifu AS
    JAMA; 2017 Sep; 318(11):1057-1058. PubMed ID: 28975291
    [No Abstract]   [Full Text] [Related]  

  • 25. Dementia care in nursing homes: a golden opportunity.
    Bonner A
    Int Psychogeriatr; 2014 Mar; 26(3):361-2. PubMed ID: 24476937
    [No Abstract]   [Full Text] [Related]  

  • 26. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.
    Stahl SM
    CNS Spectr; 2018 Oct; 23(5):291-297. PubMed ID: 30382934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
    Schneider LS; Tariot PN; Lyketsos CG; Dagerman KS; Davis KL; Davis S; Hsiao JK; Jeste DV; Katz IR; Olin JT; Pollock BG; Rabins PV; Rosenheck RA; Small GW; Lebowitz B; Lieberman JA
    Am J Geriatr Psychiatry; 2001; 9(4):346-60. PubMed ID: 11739062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics, elderly patients, and mortality risk.
    Citrome L
    South Med J; 2007 Oct; 100(10):964-5. PubMed ID: 17943033
    [No Abstract]   [Full Text] [Related]  

  • 31. Involving the resident/decision maker in antipsychotic medication use.
    Mort JR
    S D Med; 2013 Apr; 66(4):148-9. PubMed ID: 23697039
    [No Abstract]   [Full Text] [Related]  

  • 32. Restless patients in nursing homes. What is the role of drug therapy?
    Sinnett PF
    Drugs Aging; 1994 Jun; 4(6):443-8. PubMed ID: 7915556
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of acute agitation in psychotic disorders.
    Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
    Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotics in nursing homes.
    Salzman C
    J Clin Psychopharmacol; 2013 Feb; 33(1):1-2. PubMed ID: 23277258
    [No Abstract]   [Full Text] [Related]  

  • 35. Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England.
    Testad I; Auer S; Mittelman M; Ballard C; Fossey J; Donabauer Y; Aarsland D
    Int J Geriatr Psychiatry; 2010 Jul; 25(7):725-31. PubMed ID: 19823985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological soft signs in nursing home residents with Alzheimer's disease.
    Seidl U; Thomann PA; Schröder J
    J Alzheimers Dis; 2009; 18(3):525-32. PubMed ID: 19584453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.
    Miller EA; Schneider LS; Rosenheck RA
    Int Psychogeriatr; 2011 Feb; 23(1):44-53. PubMed ID: 20214847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
    Wragg RE; Jeste DV
    Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is relapse a justification for the use of high-dose antipsychotics?
    Cohen S; Chiles JA
    J Clin Psychiatry; 1990 Nov; 51(11):486-7. PubMed ID: 1977741
    [No Abstract]   [Full Text] [Related]  

  • 40. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.